Polaris Venture Management Co. V as of March 31, 2019
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 12 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cardlytics (CDLX) | 36.0 | $43M | 2.6M | 16.64 | |
| Fate Therapeutics (FATE) | 21.9 | $26M | 1.5M | 17.57 | |
| Kala Pharmaceuticals | 13.0 | $15M | 1.9M | 8.27 | |
| Neuronetics (STIM) | 9.6 | $11M | 742k | 15.25 | |
| Selecta Biosciences | 5.6 | $6.6M | 2.8M | 2.37 | |
| X4 Pharmaceuticals (XFOR) | 4.6 | $5.4M | 312k | 17.41 | |
| T2 Biosystems | 4.1 | $4.8M | 1.8M | 2.63 | |
| Trevena | 2.7 | $3.2M | 2.1M | 1.56 | |
| Genocea Biosciences | 1.0 | $1.2M | 2.0M | 0.59 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 0.8 | $1.0M | 1.8M | 0.55 | |
| Pulmatrix | 0.4 | $457k | 359k | 1.27 | |
| Dare Bioscience | 0.4 | $457k | 326k | 1.40 |
